J. Safra Sarasin Holding 13F: Cuts AZN Stake by $12M
Key Points
- J. Safra Sarasin's stake in AstraZeneca dropped from 169,998 shares to 97,180 shares, a 42.8% decrease.
- The fund's total reported value for AstraZeneca is now about $15.9 million, making up 0.67% of its overall portfolio.
- Analysts have shown positive sentiment, with CICC initiating coverage with an 'Outperform' rating and a price target of $198.
Get AstraZeneca PLC text alerts
We text you when insiders, Congress, analysts or big funds move on $AZN.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated AstraZeneca PLC alert may contain errors. Disclosures
J. Safra Sarasin Holding cut its position in AstraZeneca PLC (NYSE: AZN) by 72,818 shares in a filing on October 26, 2026. This reduction is valued at approximately $11.9 million, bringing their total stake down to 97,180 shares.
In this latest filing, J. Safra Sarasin reported a total value of $15,888,885 for its AstraZeneca shares, which now represent 0.67% of the fund's overall holdings. The fund ranks 40th out of 800 in its reported positions. This cut follows a trend of recent adjustments in the fund's portfolio.
AZN
AstraZeneca PLC
Where AstraZeneca Fits in J. Safra Sarasin's Portfolio
J. Safra Sarasin's reduced stake in AstraZeneca shows a significant change of 42.8% from the previous 169,998 shares.
Other Institutional Activity in AstraZeneca
Investor AB holds a substantial position with 51,587,810 shares, valued at about $8.9 billion. Capital International Investors increased its stake by 182,287 shares to a total of 34,576,070 shares, worth approximately $5.9 billion. Meanwhile, Legal & General Group PLC reduced its holdings by 100,819 shares, bringing its total to 25,750,245 shares, valued at around $4.4 billion.
AstraZeneca PLC Stock Down 0.3%
AstraZeneca shares closed at $172.06 on October 26, 2026, which is about equal to its recent trading price as of October 27, 2026. The stock has shown resilience in the healthcare sector, particularly in the drug manufacturing industry.
Recent Earnings
AstraZeneca reported trailing twelve-month revenue of approximately $61.4 billion and an EPS of $6.65. The company has a return on equity of 22.0% and a net margin of 17.0%. Its next earnings report is scheduled for October 30, 2026.
Dividend
AstraZeneca pays an annual dividend rate of $3.20, with a payout ratio of 46.9%.
Analysts Set New Price Targets
On August 24, 2026, CICC initiated coverage on AstraZeneca with an 'Outperform' rating and a price target of $198. The consensus among analysts remains optimistic about the stock's future performance.
About AstraZeneca
AstraZeneca PLC is a biopharmaceutical company based in Cambridge, United Kingdom. It focuses on developing and commercializing prescription medicines, particularly in the fields of oncology, cardiovascular, and respiratory diseases. The recent adjustments in J. Safra Sarasin's holdings reflect the ongoing changes in market dynamics and investor strategies.
Bottom Line
Investors should watch for AstraZeneca's upcoming earnings report on October 30, 2026, for further insights into its performance. J. Safra Sarasin's recent position cut may indicate a shift in strategy, but the company remains a key player in the healthcare sector.
Related Filing Alerts
Source: J. Safra Sarasin Holding's 13F filing on $AZN (Oct 26, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts